You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0527 Safety and Efficacy of Tocilizumab in Methotrexate-Resistant form of Polyarticular-Course Juvenile Idiopathic Arthritis: Factors Associated with Achievement of Inactive Disease Status

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Paediatric rheumatology
FRI0527 Safety and Efficacy of Tocilizumab in Methotrexate-Resistant form of Polyarticular-Course Juvenile Idiopathic Arthritis: Factors Associated with Achievement of Inactive Disease Status

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015100
Jul 2015400
Aug 2015902
Sep 20151701
Oct 2015100
Nov 2015100
Dec 2015304
Jan 20161205
Feb 20161803
Mar 2016801
Apr 2016900
May 2016100
Jun 20161001
Jul 2016200
Aug 2016700
Sep 2016701
Oct 20161000
Nov 2016100
Dec 2016200
Jan 2017600
Feb 2017100
Mar 2017300
Apr 2017500
May 2017700
Jun 20171000
Jul 2017402
Aug 2017400
Sep 2017600
Oct 20171000
Nov 20171200
Dec 20171601
Jan 20181800
Feb 20182400
Mar 20182201
Apr 20181800
May 20181400
Jun 20181000
Jul 20181000
Aug 20181400
Sep 2018401
Nov 2018200
Dec 2018200
Jan 2019100
Feb 2019801
Apr 2019400
May 2019801
Jun 2019200
Jul 2019200
Sep 2019800
Oct 2019200
Nov 2019702
Dec 2019200
Jan 2020400
Feb 2020400
Jun 2020400
Jul 2020600
Aug 2020200
Sep 20201900
Oct 2020400
Nov 2020700
Dec 2020200
Jan 2021200
Feb 2021200
Jul 2021100
Nov 2021400
Dec 2021700
Feb 2022600
Mar 20221000
Apr 2022800
May 2022800
Jun 2022200
Jul 20222200
Aug 20222400
Sep 20221000
Oct 2022800
Nov 20222001
Dec 20221000
Jan 2023800
Feb 2023600
Mar 2023200
May 2023400
Jun 20231301
Jul 2023200
Aug 2023200
Sep 2023400
Oct 20231200
Dec 2023800
Jan 2024200
Feb 2024600
Mar 2024600
Total660029